Key facts
- This page summarizes Douglas E. Williams's Form 4 filing for Climb Bio, Inc. (CLYM).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 12 Nov 2024, 17:47.
Douglas E. Williams - 11 Nov 2024 Form 4 Insider Report for Climb Bio, Inc. (CLYM)
- Reporting relationship
- Director
- Issuer ticker
- CLYM
- Reported as of
- 11 Nov 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Nov 2024, 17:47:55 UTC
- Prior SEC filing
- 12 Nov 2024
- Next SEC filing
- 19 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- Emily Pimblett, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Douglas E. Williams filed Form 4 for Climb Bio, Inc. (CLYM) on 12 Nov 2024.
Change
- Previous filing in this sequence was filed on 12 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLYM
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +20,000
- Change %
- Price
- $0.000000
- Shares after
- 20,000
- Date
- 11 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $4.06
- Footnotes
- F1
CLYM
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +6,291
- Change %
- Price
- $0.000000
- Shares after
- 6,291
- Date
- 11 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,291
- Exercise price
- $4.06
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The shares underlying the option vest in equal monthly installments from November 8, 2024 (the "Vesting Commencement Date") until the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service.
Footnote F2
The shares underlying the option vest on the earlier of June 26, 2025 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continued service.